Characteristics of subjects
Patient characteristics are summarized in Table 1 (n=103). The median
age was 13.5 years (range 1-24 years) at initial evaluation for IO; 60
(58%) were male. The most frequent cancer types were high-risk B-cell
precursor acute lymphoblastic leukemia (HR-ALL; n=28, 27%), followed by
acute myelogenous leukemia (AML; n=20, 19%). Sixty subjects received
HSCT, including autologous transplant for solid tumors (n=22). At time
of assessment, 73 were post-completion of treatment.